This invention relates generally to occlusion devices for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale, and other septal and vascular defects. In particular, this invention relates to a catch mechanism to maintain the occluder in the deployed configuration. The invention also relates to delivery systems and mechanisms for such devices.
A patent foramen ovale (PFO), illustrated in
The foramen ovale serves a desired purpose when a fetus is gestating. Because blood is oxygenated through the umbilical cord, and not through the developing lungs, the circulatory system of the fetal heart allows the blood to flow through the foramen ovale as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two overlapping layers of tissue: septum primum 14 and septum secundum 16. However, a PFO has been shown to persist in a number of adults.
The presence of a PFO is generally considered to have no therapeutic consequence in otherwise healthy adults. Paradoxical embolism via a PFO is considered in the diagnosis for patients who have suffered a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another identified cause of ischemic stroke. While there is currently no definitive proof of a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is significant evidence that patients with a PFO who have had a cerebral vascular event are at increased risk for future, recurrent cerebrovascular events. The presence of a PFO has also been linked to another condition, chronic migraine headaches. While researchers are still working on finding an explanation, PFO closure has been shown to eliminate or significantly reduce migraine headaches in many patients.
In certain cases, such as when anticoagulation is contraindicated, surgery may be necessary or desirable to close a PFO. The surgery would typically include suturing a PFO closed by attaching septum secundum to septum primum. This sutured attachment can be accomplished using either an interrupted or a continuous stitch and is a common way a surgeon shuts a PFO under direct visualization.
Umbrella devices and a variety of other similar mechanical closure devices, developed initially for percutaneous closure of atrial septal defects (ASDs), have been used in some instances to close PFOs. These devices potentially allow patients to avoid the side effects often associated with anticoagulation therapies and the risks of invasive surgery. However, umbrella devices and the like that are designed for ASDs are not optimally suited for use as PFO closure devices.
Currently available septal closure devices present drawbacks, including technically complex implantation procedures. Additionally, there are significant complications due to thrombus, fractures of the components, conduction system disturbances, perforations of heart tissue, and residual leaks. Many devices have a high septal profile and include large masses of foreign material, which may lead to unfavorable body adaptation of a device. Given that ASD devices are designed to occlude holes, many lack anatomic conformability to the flap-like anatomy of PFOs. Thus, when inserting an ASD device to close a PFO, the narrow opening and the thin flap may form impediments to proper deployment. Even if an occlusive seal is formed, the device may be deployed in the heart on an angle, leaving some components insecurely seated against the septum and, thereby, risking thrombus formation due to hemodynamic disturbances. Finally, some septal closure devices are complex to manufacture, which may result in inconsistent product performance.
Various devices and delivery systems have been developed to deliver occluders and other medical devices through body lumens. Some delivery systems of the prior art are used to deliver devices that readily expand to a delivered configuration when removed from the delivery system. Other occluders do not readily expand into a deployed configuration and techniques are used to change the configuration of the device into the deployed configuration. In the latter case, once an occluder is delivered to the desired delivery site and deployed, the occluder must have a catch system that keeps the device in the deployed configuration.
The devices and techniques disclosed herein are designed to address these and other deficiencies of prior art septal closure devices and techniques for delivering and retrieving such devices.
This description discloses a delivery system and technique(s) for delivering an implant into a desired location within the body and securing the device in the deployed configuration. The device(s) relate particularly to, but are not limited to, a septal occluder made from a polymer tube. The occluder includes a first side adapted to be disposed on one side of the septal tissue and a second side adapted to be disposed on the opposite side of the septal tissue. The first and second sides are adapted to occlude the aperture upon deployment of the device at its intended delivery location. The delivery technique, in addition to use with septal occluders, could be applied to other medical devices, such as other expandable devices constructed from an underlying tubular structure.
In one embodiment, the present invention provides a catch system that maintains the configuration of an occluder once it has been deployed. In one aspect, the catch system includes a catch member having a threaded outside surface at the proximal end that can be threadably attached to the proximal side of the occluder. The distal end of the catch member includes a flange that can apply a proximal force on the distal end of the occluder. A delivery wire having a threaded outside surface at the distal end can be threadably attached to the proximal or distal end of the catch member, so that by pulling the delivery wire in the proximal direction, a proximal force is applied to the catch member and the distal end of the occluder. The delivery system also includes a delivery catheter that can be threadably attached to the proximal end of the occluder and can be used to maintain the position thereof. During deployment, the delivery wire can be used to pull the distal end of the occluder in the proximal direction, thereby converting the occluder into an expanded profile, deployed configuration. An inner catheter having a key that fits inside a slot at the proximal end of the catch member is provided to apply an axial twisting force upon the catch member. Using the inner catheter, the proximal ends of the catch member and the occluder can be threadably attached or detached.
Before deployment, various components of the delivery system, catch system and the occluder in a reduced profile configuration can be connected and placed inside a delivery sheath. After moving the distal end of the delivery sheath past an aperture in the septum, the delivery sheath can be retracted. The delivery wire can then be used to convert the occluder to the expanded profile deployed configuration to occlude the aperture. The inner catheter can then be used to attach the proximal ends of the catch member and the occluder so that the occluder maintains the deployed configuration. After attachment, the delivery catheter can be detached from the occluder and removed. The occluder can later be retrieved if desired.
In another aspect, the catch system includes a catch member having a threaded outside surface at the proximal end that can be threadably attached to the proximal side of the occluder. The distal end of the catch member includes a flange that can apply a proximal force on the distal end of the occluder. A delivery wire forms a loop around the distal end of the catch member. Two apertures may be used to loop the delivery wire around the distal end. The delivery wire could be a polymeric material or metallic material. In some embodiments it could be Nitinol. In some embodiments, a delivery wire that can translate axial force in a pushing direction may be advantageous. The delivery system also includes a delivery catheter that can be threadably attached to the proximal end of the occluder and can be used to maintain the position thereof. During deployment, the delivery wire can be used to pull the distal end of the occluder in the proximal direction, thereby converting the occluder into an expanded profile, deployed configuration. An inner catheter having a slot at the distal end that fits a key at the proximal end of the catch member is provided to apply an axial twisting force upon the catch member. Using the inner catheter, the proximal ends of the catch member and the occluder can be threadably attached or detached.
According to at least some embodiments, the occluder is formed from a tube. According to some embodiments, the tube includes a material selected from the group consisting of metals, shape memory materials, alloys, polymers, bioabsorbable polymers, and combinations thereof. In particular embodiments, the tube includes a shape memory polymer. In particular embodiments, the tube includes nitinol. In some embodiments, the tube is formed by rolling a flat piece of material into a tubular form. According to some embodiments, the occluder is formed by cutting the tube. In other embodiments, the occluder is formed from a plurality of filaments, aligned in a tubular arrangement and bonded at selected locations. The occluder is placed in its deployment configuration by reducing the axial length of the device.
These and other aspects and embodiments of the invention are illustrated and described below.
In various aspects, the present invention provides devices, delivery/retrieval systems and techniques for delivering such devices intended to occlude an aperture within body tissue. In particular and as described in detail below, the described occluder may be used for closing an ASD, ventricular septal defect (VSD) or PFO in the atrial septum of a heart. Although the embodiments are described with reference to an ASD, VSD or PFO, one skilled in the art will recognize that the device and methods of the present invention may be used to treat other anatomical conditions. As such, the invention should not be considered limited in applicability to any particular anatomical condition. In addition, the systems and methods for delivery and retrieval, and for catching a device in a deployed state, that are aspects of the present invention may also be used in connection with other types of devices besides an occluder, in particular, devices having tubular profiles.
In this application, “distal” refers to the direction away from a catheter insertion location and “proximal” refers to the direction nearer the insertion location. Additionally, the term “delivery configuration” refers to the configuration of a device, such as an occluder, when it has a reduced profile in a delivery catheter. The term “deployed configuration” refers to the configuration of the device, such as an occluder, when it has an expanded profile, such as deployed from the catheter at the desired implantation location.
The embodiment described in conjunction with
As shown in
The tube(s) or filaments forming occluder 70 may be formed from a biocompatible metal or polymer. In at least some embodiments, the occluder 70 is formed of a bioabsorbable polymer, or a shape memory polymer. Shape memory polymers can be advantageous so that the structure of the device assists in pressing the PFO tunnel closed. In other embodiments, the occluder 70 is formed of a biocompatible metal, such as a shape memory alloy (e.g., nitinol). The thermal shape memory and/or superelastic properties of shape memory polymers and alloys permit the occluder 70 to resume and maintain its intended shape in vivo despite being distorted during the delivery process. Alternatively, or additionally, the occluder 70 may be formed of a bioabsorbable metal, such as iron, magnesium, or combinations of these and similar materials. Exemplary bioabsorbable polymers include polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of Polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety.
The cross-sectional shape of the tube may be circular or polygonal, for example square, or hexagonal. The slits 74, 84 may be disposed on the face of the polygon (i.e., the flat part) or on the intersection of the faces.
The tube can be injection molded, extruded, or constructed of a sheet of material and rolled into a tube. The sheet of material could be a single ply sheet or multiple ply. The slits that form the segments could be cut or stamped into the sheet prior to rolling the sheet into a tube to connect the ends to form an enclosed cross section. Various geometrical cross sections are possible including circular, square, hexagonal and octagonal and the joint could be at the vertex or along the flat of a wall if the cross section is of a particular geometry. Various attachment techniques could be used to join the ends of the sheet to form a tube, including welding, heat adhesives, non-heat adhesives and other joining techniques suitable for in-vivo application.
The petal configuration, illustrated in
The transformable design of occluder 70 enables occluder 70 to be delivered in a reduced profile, delivery configuration and to be converted readily, i.e., by reducing the axial length, in place to the expanded profile deployed configuration. Moreover, the conversion can readily be effected by forcing distal end 76 and proximal end 86 to move toward each other. For example, distal portion 20 and proximal portion 40 of occluder 70 may be deployed in separate steps, or both distal portion 20 and proximal portion 40 of occluder 70 may be exposed (e.g., out of the delivery catheter) prior to engaging the catch system and deployed together as the catch element is engaged. Use of the terms distal and proximal portion 20 and 40, respectively, include the loops or other geometries and configurations that are formed on the distal and proximal sides, respectively.
Occluder 70 may be made in any one of several ways. Slits 74 and 84 may be cut such that tube bends into its intended configuration following deployment in vivo. Specifically, slits 74 and 84 may be cut to produce segments 72 and 82 (as illustrated in
The catch member 50, as illustrated, is disposed in a radially central location in the occluder 70 and is schematically illustrated as a separate piece than the occluder 70. In a preferred embodiment, the distal end of the catch member includes a flange 92 (shown in FIGS. 6-8) that rests against, but not fixed to, the distal end 76 of the occluder 70. When the catch member 50 is pulled in the proximal direction, the flange 92 applies a force Fd to the distal end 76 of the occluder 70 and moves it in the proximal direction. In general, references to “occluder 70” herein may be inclusive of catch member 50, depending on the context, for example, unless separately listed or otherwise stated.
One end of the occluder, preferably the proximal end 86 of the occluder 70, is able to move with respect to the catch member 50 (and especially the catch system provided thereby) so that the distal and proximal petals 72 and 82 can move from the delivery configuration to the deployed configuration. When the proximal end of the catch member 50 is connected with the proximal end 86 of the occluder 70, the occluder is secured in its deployed configuration.
One embodiment of a delivery system 250 of the present invention will now be described with reference to
According to one embodiment, catch member 50 is made of any metal or polymer. In another embodiment, catch member 50 is made of biocompatible metal or polymer. In an alternative embodiment, catch member 50 is made of bioabsorbable or shape memory material.
In a specific embodiment, catch member 50 is made of shape memory material (e.g., nitinol). The thermal shape memory and/or superelastic properties of shape memory polymers and alloys permit the catch member 50 to resume and maintain its intended shape in vivo despite being distorted during the delivery and/or deployment process.
In one embodiment, catch member 50 is made of a bioabsorbable material. Exemplary bioabsorbable materials include polymers, such as polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of Polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety.
The proximal end 160 of the catch member 50 includes external threads 152 that cooperate with internal threads 154 of the proximal end 86 of the occluder 70. When engaged, the threaded connection formed by threads 152 and 154 operates to hold the occluder 70 in the deployed configuration. The connection can be released by unthreading the catch member 50 from the proximal end of the occluder 70. Once the connection is released, the occluder 70 can collapse into its delivery configuration and be retrieved.
In the illustrated embodiment, The proximal end 160 of the catch member 50 also includes internal threads 158 and a slot 156 (shown in dashed lines) disposed at the radial center of the catch member 50. In other embodiments, the internal threads 158 can be disposed anywhere along the length of catch member 50, i.e., at the proximal or distal ends or more centrally. The internal threads 158 are designed to cooperate with external threads 162 of the distal end of the delivery wire 164. When engaged, the threaded connection formed by threads 158 and 162 allows a force Fd to be applied to the catch member 50 when the delivery wire 164 is pulled in the proximal direction. To release the delivery wire after the deployment of the occluder 70, the threaded connection between threads 158 and 162 is disengaged.
In addition to the threaded portion 154 at the proximal end 86 of the occluder 70 to secure the catch member 50, the occluder can include additional internal threads at the center joint or connection member 78. For example, as illustrated, the connection member 78 may have threads 79 that can cooperate with the threads 152 on the catch member 50 to secure the occluder in an intermediate position. Of course, as with all the embodiments, the number of threads can vary. That is, more or fewer threads can be provided than illustrated in the exemplary embodiment.
Other mechanisms for connecting the delivery wire 164 and catheter 168 are also possible. Although
The delivery wire 164 is disposed inside inner catheter 168 and can freely slide or rotate relative to the inner catheter 168. The inner catheter 168 is slidably disposed within the delivery catheter 172. The inner catheter 168 can also extend inside the radially central portion of occluder 70 and can freely rotate or slide relative to the occluder 70. Disposed at the distal end 170 of the inner catheter 168 is a key 166 that can be inserted into the slot 156 at the proximal end 160 of the catch member 50. When inserted, the key 166 of the inner catheter 168 fits the slot 156 at the proximal end 160 of the catch member 50, so that by rotating the inner catheter 168, the catch member 50 can be rotated. Hence, upon inserting the key 166 of the inner catheter 168 to the slot 156 at the proximal end 160 of the catch member 50, the inner catheter 168 can be used to threadably engage or disengage the external threads 152 at the proximal end 160 of the catch member 50 with internal threads 154 of the occluder 70.
The delivery system includes a delivery catheter 172 for holding the proximal end 86 of the occluder 70 during the deployment or retrieval of the occluder 70. The distal end 178 of the delivery catheter 172 includes internal threads 174 that cooperate with external threads 176 at the proximal end 86 of the occluder. The delivery catheter 172 can be threadably connected to the occluder 70 using threads 174 and 176. When applying a force Fd to the distal end 76 of the occluder 70, the delivery catheter 172 can hold the position of the proximal end 86 of the occluder 70, or apply a force Fp in the opposite direction of force Fd, so that the axial length of the occluder 70 is reduced and the occluder 70 is transformed from the delivery configuration into the deployed configuration. Once the occluder 70 is deployed, the delivery catheter 172 can be disconnected from the occluder 70 and removed.
Although
As illustrated in
If retrieval is needed, the inner catheter 168 can be disposed inside the delivery catheter 172, which can be disposed inside the delivery sheath 200 and advanced together into the heart. In addition, the delivery wire 164 can be disposed inside the inner catheter 168 and inserted together with the inner catheter 168. The delivery catheter 172 engages the proximal end 86 of the occluder 70, and the delivery wire 164 engages the proximal end 160 of the catch member 50. The inner catheter 168 and delivery wire 164 is used to rotate the catch member 50 to disengage its proximal end 160 from the proximal end 86 of the occluder 70. After the occluder 70 returns to its reduced profile, delivery configuration, the occluder 70 and the catch member 50 can be withdrawn together with the delivery sheath 200.
Different from the delivery system 250 shown in
An inner catheter 258 is disposed inside the central portion of the occluder 70 and can freely rotate or slide relative to the occluder 70. The distal end of the inner catheter 258 includes a slot 274 that fits a key 272 disposed at the proximal end of the catch member 256. Using the inner catheter 258, the catch member 256 can therefore be rotated to engage the proximal end 86 of the occluder 70 locking the occluder in the deployed configuration. This delivery system 300 can be used to deploy occluder 70 in generally the same manner as the delivery system described in connection with
It will be understood that the threads 152 and 154, 174 and 176 can be of constant or varying pitches. In various embodiments, the threads could be v-form, square or acme threads, for example.
The embodiments and techniques described here are described preferably for use with a device made of a polymer and formed from a single tube. While the device is thus shown as being substantially formed from a single tubular body, which could also be made of cylindrically arranged filaments, the catch mechanism as described in the embodiments above could be used with other types of devices, including those formed from many pieces, and including devices formed from other materials, including metals, polymers, stainless steel or nitinol.
The term “bioabsorbable,” as used in the description above, is also understood to mean “bioresorbable.”
While the description above refers to “wires”, and while the term “wire” might convey a more rigid piece than a string, a suture or a filament, all these terms are essentially interchangeable with respect to the invention and any suitable element can be used. Each wire, string, suture and filament can be composed of one or more wires, strings, sutures and filaments.
In cases in which the device is made of a polymer, it can be desirable to add an additive or coating to the material to make it radiopaque to make it more visible in a wider variety of imaging techniques.
It will be appreciated that while a particular sequence of steps has been shown and described for purposes of explanation, the sequence may be varied in certain respects, or the steps may be combined, while still obtaining the desired deployment or in some cases to effect deployment in a particular way. For example, the delivery sheath may be advanced or retracted at varying times and in varying degrees, the proximal and distal portions of the occluder may be deployed into the petal configuration in a different sequence, etc. In addition, the steps could be automated.
It will be appreciated that the particular embodiments illustrated and described herein are provided by way of example only and are not intended to limit the scope of the invention, which is indicated in the appended claims.
This Application claims the benefit under 35 U.S.C. 119(e) of U.S. Provisional Application No. 60/787,987, filed on Mar. 31, 2006, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3824631 | Burstein et al. | Jul 1974 | A |
3874388 | King et al. | Apr 1975 | A |
3875648 | Bone | Apr 1975 | A |
3924631 | Mancusi, Jr. | Dec 1975 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4007743 | Blake | Feb 1977 | A |
4149327 | Hammer et al. | Apr 1979 | A |
4425908 | Simon | Jan 1984 | A |
4610674 | Suzuki et al. | Sep 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4693249 | Schenck et al. | Sep 1987 | A |
4696300 | Anderson | Sep 1987 | A |
4710181 | Fuqua | Dec 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4738666 | Fuqua | Apr 1988 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4840623 | Quackenbush | Jun 1989 | A |
4902508 | Badylak et al. | Feb 1990 | A |
4915107 | Rebuffat et al. | Apr 1990 | A |
4917089 | Sideris | Apr 1990 | A |
4921479 | Grayzel | May 1990 | A |
4956178 | Badylak et al. | Sep 1990 | A |
5021059 | Kensey et al. | Jun 1991 | A |
5037433 | Wilk et al. | Aug 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5049131 | Deuss | Sep 1991 | A |
5078736 | Behl | Jan 1992 | A |
5106913 | Yamaguchi et al. | Apr 1992 | A |
5108420 | Marks | Apr 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5163131 | Row et al. | Nov 1992 | A |
5167363 | Adkinson et al. | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5171259 | Inoue | Dec 1992 | A |
5176659 | Mancini | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5226879 | Ensminger et al. | Jul 1993 | A |
5236440 | Hlavacek | Aug 1993 | A |
5245023 | Peoples et al. | Sep 1993 | A |
5245080 | Aubard et al. | Sep 1993 | A |
5250430 | Peoples et al. | Oct 1993 | A |
5257637 | El Gazayerli | Nov 1993 | A |
5275826 | Badylak et al. | Jan 1994 | A |
5282827 | Kensey et al. | Feb 1994 | A |
5284488 | Sideris | Feb 1994 | A |
5304184 | Hathaway et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5312435 | Nash et al. | May 1994 | A |
5316262 | Koebler | May 1994 | A |
5320611 | Bonutti et al. | Jun 1994 | A |
5334217 | Das | Aug 1994 | A |
5350363 | Goode et al. | Sep 1994 | A |
5354308 | Simon et al. | Oct 1994 | A |
5364356 | Hofling | Nov 1994 | A |
5411481 | Allen et al. | May 1995 | A |
5413584 | Schulze | May 1995 | A |
5417699 | Klein et al. | May 1995 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5453099 | Lee et al. | Sep 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5480353 | Garza, Jr. | Jan 1996 | A |
5480424 | Cox | Jan 1996 | A |
5486193 | Bourne et al. | Jan 1996 | A |
5507811 | Koike et al. | Apr 1996 | A |
5534432 | Peoples et al. | Jul 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5562632 | Davila et al. | Oct 1996 | A |
5577299 | Thompson et al. | Nov 1996 | A |
5601571 | Moss | Feb 1997 | A |
5603703 | Elsberry et al. | Feb 1997 | A |
5618311 | Gryskiewicz | Apr 1997 | A |
5620461 | Muijs Van De Moer et al. | Apr 1997 | A |
5626599 | Bourne et al. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5649950 | Bourne et al. | Jul 1997 | A |
5649959 | Hannam et al. | Jul 1997 | A |
5663063 | Peoples et al. | Sep 1997 | A |
5683411 | Kavteladze et al. | Nov 1997 | A |
5690674 | Diaz | Nov 1997 | A |
5693085 | Buirge et al. | Dec 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5709707 | Lock et al. | Jan 1998 | A |
5713864 | Verkaart | Feb 1998 | A |
5717259 | Schexnayder | Feb 1998 | A |
5720754 | Middleman et al. | Feb 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5733294 | Forber et al. | Mar 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5772641 | Wilson | Jun 1998 | A |
5776162 | Kleshinski | Jul 1998 | A |
5776183 | Kanesaka et al. | Jul 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5810884 | Kim | Sep 1998 | A |
5820594 | Fontirroche et al. | Oct 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5853420 | Chevillon et al. | Dec 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5861003 | Latson et al. | Jan 1999 | A |
5865791 | Whayne et al. | Feb 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5893856 | Jacob et al. | Apr 1999 | A |
5895411 | Irie | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5902319 | Daley | May 1999 | A |
5904703 | Gilson | May 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5928250 | Koike et al. | Jul 1999 | A |
5944691 | Querns et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5955110 | Patel et al. | Sep 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5980505 | Wilson | Nov 1999 | A |
5989268 | Pugsley, Jr. et al. | Nov 1999 | A |
5993475 | Lin et al. | Nov 1999 | A |
5993844 | Abraham et al. | Nov 1999 | A |
5997575 | Whitson et al. | Dec 1999 | A |
6010517 | Baccaro | Jan 2000 | A |
6019753 | Pagan | Feb 2000 | A |
6024756 | Huebsch et al. | Feb 2000 | A |
6027519 | Stanford | Feb 2000 | A |
6030007 | Bassily et al. | Feb 2000 | A |
6056760 | Koike et al. | May 2000 | A |
6071998 | Muller et al. | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6077880 | Castillo et al. | Jun 2000 | A |
6079414 | Roth | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6096347 | Geddes et al. | Aug 2000 | A |
6106913 | Scardino et al. | Aug 2000 | A |
6113609 | Adams | Sep 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6132438 | Fleischman et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6165204 | Levinson et al. | Dec 2000 | A |
6168588 | Wilson | Jan 2001 | B1 |
6171329 | Shaw et al. | Jan 2001 | B1 |
6174322 | Schneidt et al. | Jan 2001 | B1 |
6174330 | Stinson | Jan 2001 | B1 |
6183443 | Kratoska et al. | Feb 2001 | B1 |
6187039 | Hiles et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6197016 | Fourkas et al. | Mar 2001 | B1 |
6199262 | Martin | Mar 2001 | B1 |
6206895 | Levinson | Mar 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6217590 | Levinson | Apr 2001 | B1 |
6221092 | Koike et al. | Apr 2001 | B1 |
6227139 | Nguyen et al. | May 2001 | B1 |
6228097 | Levinson et al. | May 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6245080 | Levinson | Jun 2001 | B1 |
6245537 | Williams et al. | Jun 2001 | B1 |
6261309 | Urbanski | Jul 2001 | B1 |
6265333 | Dzenis et al. | Jul 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6277138 | Levinson et al. | Aug 2001 | B1 |
6277139 | Levinson et al. | Aug 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6306150 | Levinson | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6312443 | Stone | Nov 2001 | B1 |
6312446 | Huebsch et al. | Nov 2001 | B1 |
6315791 | Gingras et al. | Nov 2001 | B1 |
6316262 | Huisman et al. | Nov 2001 | B1 |
6319263 | Levinson | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6342064 | Koike et al. | Jan 2002 | B1 |
6344048 | Chin et al. | Feb 2002 | B1 |
6344049 | Levinson et al. | Feb 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6348041 | Klint et al. | Feb 2002 | B1 |
6352552 | Levinson et al. | Mar 2002 | B1 |
6355052 | Neuss et al. | Mar 2002 | B1 |
6356782 | Sirimanne et al. | Mar 2002 | B1 |
6358238 | Sherry | Mar 2002 | B1 |
6364853 | French et al. | Apr 2002 | B1 |
6371904 | Sirimanne et al. | Apr 2002 | B1 |
6375625 | French et al. | Apr 2002 | B1 |
6375671 | Kobayashi et al. | Apr 2002 | B1 |
6379342 | Levinson | Apr 2002 | B1 |
6379368 | Corcoran et al. | Apr 2002 | B1 |
6387104 | Pugsley, Jr. et al. | May 2002 | B1 |
6398796 | Levinson | Jun 2002 | B2 |
6402772 | Amplatz et al. | Jun 2002 | B1 |
6419669 | Frazier et al. | Jul 2002 | B1 |
6426145 | Moroni | Jul 2002 | B1 |
6436088 | Frazier et al. | Aug 2002 | B2 |
6440152 | Gainor et al. | Aug 2002 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6460749 | Levinson et al. | Oct 2002 | B1 |
6478773 | Gandhi et al. | Nov 2002 | B1 |
6482224 | Michler et al. | Nov 2002 | B1 |
6488706 | Solymar et al. | Dec 2002 | B1 |
6494846 | Margolis | Dec 2002 | B1 |
6494888 | Laufer et al. | Dec 2002 | B1 |
6508828 | Akerfeldt et al. | Jan 2003 | B1 |
6514515 | Williams | Feb 2003 | B1 |
6548569 | Williams et al. | Apr 2003 | B1 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6551344 | Thill | Apr 2003 | B2 |
6585719 | Wang | Jul 2003 | B2 |
6585755 | Jackson et al. | Jul 2003 | B2 |
6596013 | Yang et al. | Jul 2003 | B2 |
6599448 | Ehrhard, Jr. et al. | Jul 2003 | B1 |
6610764 | Martin et al. | Aug 2003 | B1 |
6623508 | Shaw et al. | Sep 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6626936 | Stinson | Sep 2003 | B2 |
6629901 | Huang | Oct 2003 | B2 |
6666861 | Grabek | Dec 2003 | B1 |
6669713 | Adams | Dec 2003 | B2 |
6669722 | Chen et al. | Dec 2003 | B2 |
6689589 | Huisman et al. | Feb 2004 | B2 |
6712804 | Roue et al. | Mar 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6726696 | Houser et al. | Apr 2004 | B1 |
6828357 | Martin et al. | Dec 2004 | B1 |
6838493 | Williams et al. | Jan 2005 | B2 |
6855126 | Flinchbaugh | Feb 2005 | B2 |
6867247 | Williams et al. | Mar 2005 | B2 |
6867248 | Martin et al. | Mar 2005 | B1 |
6867249 | Lee et al. | Mar 2005 | B2 |
6921410 | Porter | Jul 2005 | B2 |
7223271 | Muramatsu et al. | May 2007 | B2 |
7871419 | Devellian et al. | Jan 2011 | B2 |
7918872 | Mitelberg et al. | Apr 2011 | B2 |
8062325 | Mitelberg et al. | Nov 2011 | B2 |
20010010481 | Blanc et al. | Aug 2001 | A1 |
20010014800 | Frazier et al. | Aug 2001 | A1 |
20010025132 | Alferness et al. | Sep 2001 | A1 |
20010034537 | Shaw et al. | Oct 2001 | A1 |
20010034567 | Allen et al. | Oct 2001 | A1 |
20010037129 | Thill | Nov 2001 | A1 |
20010039435 | Roue et al. | Nov 2001 | A1 |
20010039436 | Frazier et al. | Nov 2001 | A1 |
20010041914 | Frazier et al. | Nov 2001 | A1 |
20010041915 | Roue et al. | Nov 2001 | A1 |
20010044639 | Levinson | Nov 2001 | A1 |
20010049492 | Frazier et al. | Dec 2001 | A1 |
20020010481 | Jayaraman | Jan 2002 | A1 |
20020019648 | Akerfeldt et al. | Feb 2002 | A1 |
20020022859 | Hogendijk | Feb 2002 | A1 |
20020022860 | Borillo et al. | Feb 2002 | A1 |
20020026208 | Roe et al. | Feb 2002 | A1 |
20020029048 | Miller | Mar 2002 | A1 |
20020032459 | Horzewski et al. | Mar 2002 | A1 |
20020032462 | Houser et al. | Mar 2002 | A1 |
20020034259 | Tada | Mar 2002 | A1 |
20020035374 | Borillo et al. | Mar 2002 | A1 |
20020043307 | Ishida et al. | Apr 2002 | A1 |
20020049457 | Kaplan et al. | Apr 2002 | A1 |
20020052572 | Franco et al. | May 2002 | A1 |
20020058989 | Chen et al. | May 2002 | A1 |
20020077555 | Schwartz | Jun 2002 | A1 |
20020095174 | Tsugita et al. | Jul 2002 | A1 |
20020096183 | Stevens et al. | Jul 2002 | A1 |
20020099389 | Michler et al. | Jul 2002 | A1 |
20020099390 | Kaplan et al. | Jul 2002 | A1 |
20020103492 | Kaplan et al. | Aug 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020111537 | Taylor et al. | Aug 2002 | A1 |
20020111637 | Kaplan et al. | Aug 2002 | A1 |
20020111647 | Khairkhahan et al. | Aug 2002 | A1 |
20020120323 | Thompson et al. | Aug 2002 | A1 |
20020128680 | Pavlovic | Sep 2002 | A1 |
20020129819 | Feldman et al. | Sep 2002 | A1 |
20020143292 | Flinchbaugh | Oct 2002 | A1 |
20020164729 | Skraly et al. | Nov 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020183786 | Girton | Dec 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020183823 | Pappu | Dec 2002 | A1 |
20020198563 | Gainor et al. | Dec 2002 | A1 |
20030004533 | Dieck et al. | Jan 2003 | A1 |
20030023266 | Welch et al. | Jan 2003 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030045893 | Ginn | Mar 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030055455 | Yang et al. | Mar 2003 | A1 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030059640 | Marton et al. | Mar 2003 | A1 |
20030065379 | Babbs et al. | Apr 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030171774 | Freudenthal et al. | Sep 2003 | A1 |
20030191495 | Ryan et al. | Oct 2003 | A1 |
20030195530 | Thill | Oct 2003 | A1 |
20030204203 | Khairkhahan et al. | Oct 2003 | A1 |
20040044361 | Frazier et al. | Mar 2004 | A1 |
20040073242 | Chanduszko | Apr 2004 | A1 |
20040133236 | Chanduszko | Jul 2004 | A1 |
20040176799 | Chanduszko et al. | Sep 2004 | A1 |
20040210301 | Obermiller | Oct 2004 | A1 |
20040234567 | Dawson | Nov 2004 | A1 |
20050025809 | Hasirci et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050113868 | Devellian et al. | May 2005 | A1 |
20050182426 | Adams et al. | Aug 2005 | A1 |
20050267523 | Devellian et al. | Dec 2005 | A1 |
20050273135 | Chanduszko et al. | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060122647 | Callaghan et al. | Jun 2006 | A1 |
20060265004 | Callaghan et al. | Nov 2006 | A1 |
20060271089 | Alejandro et al. | Nov 2006 | A1 |
20070010851 | Chanduszko et al. | Jan 2007 | A1 |
20070167981 | Opolski | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
9413645 | Oct 1994 | DE |
0362113 | Apr 1990 | EP |
0474887 | Mar 1992 | EP |
0 839 549 | May 1998 | EP |
0 861 632 | Sep 1998 | EP |
1013227 | Jun 2000 | EP |
1046375 | Oct 2000 | EP |
1222897 | Jul 2002 | EP |
WO-9625179 | Aug 1996 | WO |
WO-9631157 | Oct 1996 | WO |
WO-9807375 | Feb 1998 | WO |
WO-9808462 | Mar 1998 | WO |
WO-9816174 | Apr 1998 | WO |
WO-9829026 | Jul 1998 | WO |
WO-9851812 | Nov 1998 | WO |
WO-9905977 | Feb 1999 | WO |
WO-9818864 | Apr 1999 | WO |
WO-9918862 | Apr 1999 | WO |
WO-9918864 | Apr 1999 | WO |
WO-9918870 | Apr 1999 | WO |
WO-9918871 | Apr 1999 | WO |
WO-9930640 | Jun 1999 | WO |
WO-9966846 | Dec 1999 | WO |
WO-0027292 | May 2000 | WO |
WO-0044428 | Aug 2000 | WO |
WO-0108600 | Feb 2001 | WO |
WO-0119256 | Mar 2001 | WO |
WO-0121247 | Mar 2001 | WO |
WO-0128432 | Apr 2001 | WO |
WO-0130268 | May 2001 | WO |
WO-0178596 | Oct 2001 | WO |
WO-0193783 | Dec 2001 | WO |
WO-0217809 | Mar 2002 | WO |
WO-0224106 | Mar 2002 | WO |
WO-03001893 | Jan 2003 | WO |
WO-03024337 | Mar 2003 | WO |
WO-03053493 | Jul 2003 | WO |
WO-03059152 | Jul 2003 | WO |
WO-03063732 | Aug 2003 | WO |
WO-03077733 | Sep 2003 | WO |
WO-03082076 | Oct 2003 | WO |
WO-03103476 | Dec 2003 | WO |
WO-2004032993 | Apr 2004 | WO |
WO-2004037333 | May 2004 | WO |
WO-2004043266 | May 2004 | WO |
WO-2004043508 | May 2004 | WO |
WO-2004052213 | Jun 2004 | WO |
WO-2005006990 | Jan 2005 | WO |
WO-2005018728 | Mar 2005 | WO |
WO-2005027752 | Mar 2005 | WO |
WO-2005074813 | Aug 2005 | WO |
WO-2005092203 | Oct 2005 | WO |
WO-2005110240 | Nov 2005 | WO |
WO-2005112779 | Dec 2005 | WO |
WO-2006036837 | Apr 2006 | WO |
WO-2006102213 | Sep 2006 | WO |
Entry |
---|
Athanasion, T., “Coronary Artery Bypass with the Use of a Magnetic Distal Anastomotic Device: Surgical Technique and Preliminary Experience,” The Heart Surgery Forum #2004-1024, 2004, 4 pgs. |
Bachthaler, M. et al., “Corrosion of Tungsten Coils After Peripheral Vascular Embolization Theraphy: Influence on Outcome and Tungsten Load”, Catherization and Cardiovascular Interventions, vol. 62, pp. 380-384, 2004. |
European Examination Report, European Application No. 04781644.2, mailed Aug. 23, 2007 (3 Pages). |
Falk, V., “Facilitated Endoscopic Beating Heart Coronary Artery Bypass Grafting Using a Magentic Coupling Device,” Journal of Thoracic and Cardiovascular Surgery, vol. 126,(5), pp. 1575-1579. |
Filsoufi, F., et al., “Automated Distal Coronary Bypass with a Novel Magnetic Coupler (MVP system),” J. Thoracic and Cardiovascular Surgery, vol. 127(1), pp. 185-192. |
International Search Report, International Application No. PCT/US02/40850 mailed Jun. 19, 2003 (4 pgs). |
International Search Report, International Application No. PCT/US03/01050, mailed Jul. 8, 2003 (1 pg). |
International Search Report, International Application No. PCT/US03/09051, mailed Sep. 29, 2003 (2 pgs). |
International Search Report, International Application No. PCT/US03/17390, mailed Oct. 6, 2003 (2 pgs). |
International Search Report, International Application No. PCT/US03/17715, mailed Mar. 24, 2004 (2 pgs). |
International Search Report, International Application No. PCT/US03/32133, mailed Apr. 22, 2004 (1 pg). |
International Search Report, International Application No. PCT/US03/34003 mailed Oct. 3, 2004 (4 pgs). |
International Search Report, International Application No. PCT/US03/35479, mailed Apr. 14, 2004 (2 pgs). |
International Search Report, International Application No. PCT/US03/35998 mailed Jun. 16, 2004 (5 pgs). |
International Search Report, International Application No. PCT/US03/39253, mailed Apr. 19, 2004 (4 pgs). |
International Search Report, International Application No. PCT/US04/022643, mailed Mar. 31, 2005 (2 pgs). |
International Search Report, International Application No. PCT/US04/026998, mailed Apr. 22, 2005 (5 pgs). |
International Search Report, International Application No. PCT/US04/029978, mailed Jan. 26, 2005 (3 pgs). |
International Search Report, International Application No. PCT/US05/006703, mailed Jul. 25, 2005 (3 pgs). |
International Search Report, International Application No. PCT/US05/013705 mailed Aug. 4, 2005 (4 pgs). |
International Search Report, International Application No. PCT/US05/015382, mailed Oct. 6, 2005 (4 pgs). |
International Search Report, International Application No. PCT/US06/009978, mailed Jul. 13, 2006 (2 pgs). |
International Search Report, International Application No. PCT/US07/065532, mailed Sep. 14, 2007 (5 pgs). |
International Search Report, International Application No. PCT/US2007/065526, mailed Aug. 8, 2007 (4 pgs). |
International Search Report, International Application No. PCT/US2007/065541, mailed Aug. 7, 2007 (4 pgs). |
International Search Report, International Application No. PCT/US97/14822, mailed Feb. 20, 1998 (2 pgs). |
International Search Report, International Application No. PCT/US97/17927, mailed Feb. 10, 1998 (1 pg). |
Isotalo, T. et al., “Biocompatibility Testing of a New Bioabsorbable X-Ray Positive SR-PLA 96/4 Urethral Stent”, The Journal of Urology, vol. 163, pp. 1764-1767, Nov. 1999. |
Kimura, A., et al., “Effects of Neutron Irradiation on the Transformation Behavior in Ti—Ni Alloys,” Abstract, Proceedings of the Int'l Conf. on Mariensitic Transformations, 1992, pp. 935-940. |
Klima, U., “Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting,” Circulation, 2004, II-55-II-60. |
Meier, MD, Bernhard et al., “Contemporary Management of Patent Foramen Ovale,” American Heart Association, Inc., Circulation, 2003, vol. 107, pp. 5-9. |
Nat'l Aeronautics and Space Administration, “55-Nitinol—The Alloy with a Memory: Its Physical Metallurgy, Properties and Applications,” NASA Report, pp. 24-25. |
Parviainen, M. et al., “A New Biodegradable Stent for the Pancreaticojejunal Anastomosis After Pancreaticoduodenal Resection: In Vitro Examination and Pilot Experiences in Humans”, Pancreas, vol. 21, No. 1, pp. 14-21, 2000. |
Ramanathan, G., et al., “Experimental and Computational Methods for Shape Memory Alloys,” 15th ASCE Engineering Mechanics Conference, Jun. 2-5, 2002. |
Ruddy, A.C. et al., “Rheological, Mechanical and Thermal Behaviour of Radipaque Filled Polymers”, Polymer Processing Research Centre, School of Chemical Engineering, Queen's University of Belfast , 5 pages. |
Ruiz, et al., “The Puncture Technique: a New Method for Transcatheter Closure of Patent Foramen Ovale,” Catheterization and Cardiovascular Interventions, 2001, vol. 53, pp. 369-372. |
Shabalovskaya, S., “Surface, Corrosion amd Biocompatibility Aspects of Nitinol as and Implant Material,” Bio-Medical Materials and Engineering, 2002, vol. 12, pp. 69-109. |
SMST-2000, “Proceedings of the International Conference on Shape Memory and Superelastic Technologies,” Apr. 30 to May 4, 2000, Asilomar Conference Center (3 pgs). |
Stockel, “Nitinol Medical Devices and Implants,” SMST-2000 Conference Proceedings, 2001, pp. 531-541. |
Uchil, J., “Shape Memory Alloys—Characterization Techniques,” Pramana—Journal of Physics, 2002, vol. 58(5)(6), pp. 1131-1139. |
Vaajanen, A. et al., “Expansion and Fixation Properties of a New Braided Biodegradable Urethral Stent: an Experimental Study in the Rabbit”, The Journal of Urology, vol. 169, pp. 1771-1174, Mar. 2003. |
European Examination Report, European Application No. 03729663.9, mailed Jul. 16, 2008 (5 Pages). |
European Examination Report, European Application No. 03731562.9, mailed Jul. 18, 2008 (3 Pages). |
European Examination Report, European Application No. 03779297.5, mailed Mar. 15, 2007 (6 Pages). |
European Search Report, European Application No. 03729663.9, mailed Feb. 20, 2008 (3 Pages). |
International Search Report and Written Opinion, International Patent Application No. PCT/US06/41255, mailed Jun. 13, 2008 (6 pgs). |
International Search Report and Written Opinion, International Patent Application No. PCT/US08/59429, mailed Sep. 5, 2008 (9 pgs). |
International Search Report for International Patent Application No. PCT/AU03/00759, filed Jun. 19, 2003. |
International Search Report, International Application No. PCT/US05/34276, mailed Oct. 9, 2007. |
International Search Report, International Patent Application No. PCT/US07/065546, mailed Oct. 29, 2007. 4 pages. |
Number | Date | Country | |
---|---|---|---|
20070276415 A1 | Nov 2007 | US |
Number | Date | Country | |
---|---|---|---|
60787987 | Mar 2006 | US |